Claim denial rates have climbed past 11 percent industry-wide, and US providers now spend more than $25.7 billion every year just reworking denied claims, according to Premier. Premier The platforms providers are evaluating in 2026 are no longer rules-based scrubbers. They are AI-native systems that prioritize recovery work by dollar value, surface denial root causes across payers and service lines, and run AI agents that draft appeals in minutes instead of hours. This guide compares the eight AI-powered denials platforms providers and healthcare systems are shortlisting in 2026, starting with DataRovers Denials 360.

The economics of working a denial have inverted.

A decade ago, almost every denied claim was worth chasing. Today, the cost of working a single denial has climbed to roughly $57 per claim, according to Premier Premier, and complex specialty appeals can run above $118.

The result is significant. McKinsey estimates that as many as 60 percent of denied claims are never appealed at all, because the recovery is not worth the rework. McKinsey 2026

That abandoned revenue is enormous. According to Premier's national survey of hospitals and health systems, US providers spent an estimated $25.7 billion on claims adjudication in 2023, a 23 percent increase over the previous year. Nearly $18 billion of that was spent on claims that were ultimately overturned. In other words, providers are paying repeatedly for revenue they have already earned. Premier

The American Hospital Association reports that hospitals spent $43 billion in 2025 trying to collect payments insurers owe for care already delivered. AHA 2025 Initial denial rates have climbed steadily, and specialty environments routinely report rates above 20 percent.

$25.7B
Annual spend on denial rework, US hospitals and providers
Premier, 2024 survey
60%
Of denied claims that are never appealed at all
McKinsey, January 2026
$43B
US hospital spend chasing payments from insurers in 2025
AHA Costs of Caring

Last-generation denial tools cannot close this gap. The AI-powered platforms that have emerged in 2026 are categorically different. They score every denied claim by recovery probability, surface root causes across payers and service lines, and run AI agents that handle appeals in minutes.

Here are the eight platforms providers and healthcare systems are shortlisting in 2026.

What separates an AI denials platform from a legacy denial tool

Three capabilities matter more than feature checklists.

Recovery-probability scoring

AI-powered platforms rank denials by overturn likelihood, payer filing windows, and dollar value at stake, rather than by submission date. This is the single biggest operational shift in modern denial management.

Evidence-based appeals

Appeals that overturn cite specific clinical documentation from the patient record, not templated language. The 2026 platforms generate appeal packets grounded in real evidence, with full audit trails.

Closed-loop root-cause intelligence

The denial pattern that repeats is the one no platform addressed upstream. Modern tools feed root cause back into upstream workflows, so the same denials stop recurring.

Agent-driven automation

AI agents that run across a queue with one click, handling prior authorization assessments, appeal packaging, payer policy lookup, and custom policy enforcement, are the new bar in 2026.

With those capabilities as the bar, here are the eight platforms providers are evaluating in 2026.

The 8 AI-powered denials platforms in 2026

2

Waystar

Waystar is one of the most widely deployed RCM platforms in the United States, processing roughly $1.8 trillion in annual claims and touching close to half of the patient population.

The denials module pairs that network scale with AI-driven prediction and a payer-specific intelligence layer. Its strongest feature is the prioritization engine, where denials are scored by overturn probability and revenue at stake.

The platform also includes automated appeal-letter generation, claim status monitoring, and trend dashboards segmented by payer, reason code, and service line.

Best for Mid-to-large hospital systems that want broad payer-network connectivity inside a single enterprise platform.
3

Innovaccer

Innovaccer brings a data-platform-first approach to denials. Its Healthcare Intelligence Cloud unifies clinical, claims, and operational data, and its denial management layer sits on top of that unified foundation.

The denial product offers root-cause analytics, payer pattern detection, and workflow automation. Its differentiator is the underlying data fabric, which connects denial intelligence to the broader population health, care management, and provider analytics workflows on the same platform.

For health systems already standardized on Innovaccer for analytics, the denial module extends naturally into the existing data ecosystem.

Best for Health systems already running Innovaccer's data platform that want denial management connected to their broader clinical and analytics stack.
4

Experian Health (ClaimSource with AI Advantage)

Experian Health concentrates its intelligence on the front-end of the workflow.

The AI Advantage modules (Predictive Denials and Denial Triage) score claims against historical payer-specific denial patterns. This lets billing teams intervene early on at-risk claims.

The denials analytics layer adds root-cause analysis by reason code, payer, and service line. ClaimSource has been a multi-year Best in KLAS winner for Claims Management.

Best for Providers prioritizing KLAS-certified claim scrubbing and upstream eligibility intelligence.
5

Optum (A/R Recovery and Denial Management)

Optum takes a hybrid services approach.

Rather than deploying a tool for internal teams to operate, Optum embeds HFMA-certified revenue cycle specialists into existing hospital workflows. They work backlogs, identify underpayments, and trend denials, supported by Optum's automation and analytics infrastructure.

The launch of Optum Integrity One in 2025 added an integrated, AI-powered RCM layer to the offering.

Best for Hospitals with significant denial backlogs or aged AR that want a managed-services model.
6

FinThrive (Fusion)

FinThrive Fusion is an AI intelligence layer embedded across the FinThrive RCM platform.

Rather than a standalone denials product, Fusion connects EHR, billing, and payer data into a unified fabric that powers predictive denial models across the revenue cycle. The Denials and Underpayments Analyzer surfaces both denial risk and contract underpayments inside enterprise dashboards.

Agentic AI workflows automate high-volume, rules-based denial intervention tasks.

Best for Large healthcare systems already operating within the FinThrive RCM ecosystem.
7

AKASA

AKASA builds on generative AI tuned specifically for the healthcare revenue cycle.

Its models are trained on each health system's own clinical and financial data, rather than relying on generic foundation models. The platform unifies coding, CDI, and denial workflows to close documentation gaps before they become denials. Its GenAI appeal generation extracts clinical evidence directly from the medical record.

AKASA overlays existing EHR systems without requiring infrastructure replacement.

Best for Health systems prioritizing generative AI tuned to their own data, with a strong emphasis on CDI-to-billing integration.
8

Rivet (Resolve)

Rivet Resolve is purpose-built for resolution efficiency at the team level.

Designed as a hands-on tool for billing teams, it combines customizable worklists, batch processing, and workflow automation, all without the contingency or percentage-of-collections fees common in legacy denial vendors. Resolve also auto-detects underpayments and supports bulk resubmissions.

Its strength is operational density rather than enterprise breadth.

Best for Small to mid-size practices, billing companies, and lean RCM teams that need focused denial resolution without contingency fees.

How to choose the right platform

Four questions narrow the field faster than any feature checklist.

What is your dominant denial pattern?

Eligibility-heavy and authorization-heavy denials favor front-end platforms like Experian Health. Clinical and specialty-driven denials favor platforms with root-cause intelligence and evidence-based appeals, which is where DataRovers Denials 360 differentiates most clearly.

What does your data foundation look like?

Fragmented data environments need platforms that bring their own analytics and root-cause layer. Consolidated environments, including health systems already on Innovaccer or FinThrive, extract more from any platform they choose.

Software, services, or both?

Software-first deployments require internal staffing capacity. Hybrid models like Optum reduce that burden but add services fees.

Are root causes addressed or just managed?

Tools that automate appeals without fixing the upstream cause leave the same denial pattern in place quarter after quarter. This is the question that ultimately separates the eight platforms.

83%

of healthcare organizations using AI in their revenue cycle reported denial reductions of at least 10 percent within six months, with 39 percent seeing cash flow improvements above 10 percent in the same window. Black Book Operating with last-generation tooling now costs measurable basis points of margin.

2026 AI denials platform comparison

PlatformBest ForAI ApproachNotable Differentiator
DataRovers Denials 360 Medium-to-large hospitals with high denial volume AI-native end-to-end with RCM Agent (4 skills) Smart Queue triage and the RCM Agent. Appeals in 2 minutes vs 2 hours, 10x productivity.
Waystar Mid-to-large hospital systems Predictive analytics on network-scale claims data $1.8T in annual claims processed, with deep payer network intelligence.
Innovaccer Health systems on Innovaccer's data platform Data-platform-first denial intelligence Unified data fabric connecting denials to population health and analytics.
Experian Health Front-end claim scrubbing and upstream eligibility Predictive risk scoring on outgoing claims AI Advantage modules, backed by Experian's consumer and identity data assets.
Optum Hospitals with large backlogs or aged AR Hybrid managed services and AI automation HFMA-certified specialists embedded in hospital workflows.
FinThrive (Fusion) Large enterprise healthcare systems Embedded agentic AI across the full RCM platform Cross-cycle intelligence with a Denials and Underpayments Analyzer.
AKASA Generative AI for CDI and denial prevention Generative AI tuned per health system Per-customer models trained on clinical and financial data.
Rivet (Resolve) Small to mid-size practices and billing companies Workflow automation with denial and underpayment detection No contingency fees, with batch resolution and resubmission workflows.

Cut Denial Workload by 10x with DataRovers Denials 360

DataRovers Denials 360 gives medium and large hospitals an AI-native platform that discovers root causes, prioritizes claims into Smart Queues, manages every appeal in one place, and runs an RCM Agent across every queue in a single click. Appeals that used to take hours now take minutes.

Book a Demo with DataRovers No commitment required · Personalized to your health system

Frequently Asked Questions

What is an AI-powered denials platform?
An AI-powered denials platform uses machine learning and AI agents to score denied claims by recovery probability, draft payer-specific appeals, and surface root-cause patterns across payers and service lines. The most advanced 2026 platforms, including DataRovers Denials 360, run AI agents that complete prior authorization assessments and full appeal packages in minutes.
Which AI denials platform is best for providers and healthcare systems in 2026?
The right platform depends on denial mix, data foundation, and whether the organization needs software, services, or both. For medium and large hospitals with significant denied-claim volume that want an AI-native platform with agent-driven appeals, DataRovers Denials 360 leads the 2026 evaluation. Waystar leads on network scale, Innovaccer on integrated data platforms, Experian Health on front-end claim scrubbing, and Optum on managed-services delivery.
How much do claim denials cost US providers each year?
According to Premier, US providers spent an estimated $25.7 billion on claims adjudication in 2023, with nearly $18 billion of that spent on claims that were ultimately overturned. The American Hospital Association reports that hospitals spent $43 billion in 2025 trying to collect payments from insurers for care already delivered. The administrative cost per denied claim now averages roughly $57, with complex appeals running above $118.
How does AI actually reduce denial workload?
McKinsey projects that AI can reduce cost-to-collect by 30 to 60 percent. The savings come from prioritizing high-yield recovery work, and recovering the 60 percent of denials that are never appealed because manual rework cost exceeds recovery value. With AI agents, such as the RCM Agent in DataRovers Denials 360, appeal packages that took two hours now take two minutes.
What capabilities should providers prioritize in 2026?
Three capabilities matter most: recovery-probability scoring on every claim, evidence-based appeal generation with audit trails, and closed-loop root-cause intelligence that feeds patterns back into upstream workflow. AI agents that handle prior authorization assessment, full appeal packaging, payer policy application, and custom policy enforcement are the new bar.
Can smaller provider organizations use these platforms?
Enterprise platforms like Waystar, Innovaccer, and FinThrive target large healthcare systems, while Rivet Resolve is built for smaller practices. DataRovers Denials 360 is optimized for medium-to-large hospitals with the denied-claim volume to benefit from Smart Queues and agent-driven automation.